| Conversion of Sox2-dependent Merkel cell carcinoma to a differentiated neuron-like phenotype by T antigen inhibition A Harold, Y Amako, J Hachisuka, Y Bai, MY Li, L Kubat, J Gravemeyer, ... Proceedings of the National Academy of Sciences 116 (40), 20104-20114, 2019 | 62 | 2019 |
| Transcriptional programs driving shear stress-induced differentiation of kidney proximal tubule cells in culture HJ Park, Z Fan, Y Bai, Q Ren, Y Rbaibi, KR Long, ML Gliozzi, ... Frontiers in physiology 11, 587358, 2020 | 27 | 2020 |
| 3′-UTR shortening contributes to subtype-specific cancer growth by breaking stable ceRNA crosstalk of housekeeping genes Z Fan, S Kim, Y Bai, B Diergaarde, HJ Park Frontiers in Bioengineering and Biotechnology 8, 334, 2020 | 16 | 2020 |
| The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer S Kim, YL Bai, Z Fan, B Diergaarde, GC Tseng, HJ Park Briefings in Bioinformatics 22 (3), bbaa191, 2021 | 13 | 2021 |
| A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor-and cell type-specific … P Ziegler, Y Tian, Y Bai, S Abrahamsson, A Bäckerholm, AS Reznik, ... PLoS Pathogens 17 (4), e1009041, 2021 | 13 | 2021 |
| Screen technical noise in single cell RNA sequencing data YL Bai, M Baddoo, EK Flemington, HN Nakhoul, YZ Liu Genomics 112 (1), 346-355, 2020 | 12 | 2020 |
| 605 Neoadjuvant vidutolimod (Vidu) and nivolumab (Nivo) results in MPR and immune activation in high-risk resectable melanoma (MEL): final phase II clinical trial results A Karunamurthy, JM Chauvin, R Morrison, Y Bai, J Sun, H Wang, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 3 | 2022 |
| scMAPA: Identification of cell-type–specific alternative polyadenylation in complex tissues Y Bai, Y Qin, Z Fan, RM Morrison, KN Nam, HM Zarour, R Koldamova, ... Gigascience 11, giac033, 2022 | 3 | 2022 |
| Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma D Davar, A Karunamurthy, JM Chauvin, R Morrison, Y Bai, J Sun, J Stein, ... | 2 | 2022 |
| The microRNA target site profile is a novel biomarker in the immunotherapy response Y Bai, Y Li, Y Qin, X Yang, GC Tseng, S Kim, HJ Park Frontiers in Oncology 13, 1225221, 2023 | 1 | 2023 |
| Elucidating the role of alternative polyadenylation in cancer by integrated transcriptomic analysis Y Bai University of Pittsburgh, 2023 | | 2023 |
